We are international
• treatment options TEXT SIZE   
frontline therapy

Dr. Moreau - A Phase 3 Prospective Randomized International Study (MMY-3021) Comparing Subcutaneous and Intravenous Administration of Bortezomib In Patients with Relapsed Multiple Myeloma
Philippe Moreau, MD
University Hospital
Nantes, France

To view the video full screen, click on the small button next to the volume control in the lower right hand corner.

 related articles